© 2021 MJH Life Sciences and Pharmacy Times. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
May 10, 2021
The percentage of patients who received an opioid among all ED visits during the 2018 shortage fell significantly from 11.5% pre-shortage to 8.5% during, and did not return to baseline once the shortage had ended.
May 07, 2021
Overdose rates were two and a half times higher among patients who filled an opioid prescription following a dental procedure.
May 03, 2021
Twenty percent of the pharmacies contacted indicated they would not dispense buprenorphine, with independent pharmacies and those in southern US states found significantly more likely to restrict the drug.
April 30, 2021
Study finds that cannabidiol (CBD) and expectancies for receiving CBD do not appear to reduce experimental pain intensity but do make the pain feel less unpleasant.
April 26, 2021
This is the first systematic literature review on the association of back pain and mortality.
April 14, 2021
Errors related to extended-release opioids and COVID-19 vaccines warrant attention and should be a priority.
March 30, 2021
Increased expansion and availability of naloxone may prove to be a monumental aspect of the public health response to the opioid crisis.
March 24, 2021
The FDA has approved the submission of a supplemental new drug application (sNDA) that expands the use of bupivacaine liposome injectable suspension to include patients aged 6 years and older for single-dose infiltration as a postsurgical local analgesia.
March 18, 2021
The study results reiterate the importance of interventions to lower prescribing rates of potentially inappropriate drugs among older adults.
March 16, 2021
Preliminary research by the American Heart Association suggests the opioid epidemic in the United States may have led to an increase in the number of strokes due to bacterial infections of the heart (infective endocarditis).